Patients with I-PSS ( International Prostate Symptom Score ) @ or greater , peak urinary flow rate @ to @ ml per second and total prostate volume @ to @ ml were randomized @:@ to a single intraprostatic treatment of onabotulinumtoxinA @ U or placebo .